Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging

J Magn Reson Imaging. 2002 Aug;16(2):217-23. doi: 10.1002/jmri.10151.

Abstract

Purpose: To examine magnetic resonance coronary artery imaging after NC100150-Injection.

Materials and methods: Breath-hold and navigator-gated images were acquired in five patients.

Results: Breath-hold image quality, coronary artery-fat SDNR, and coronary artery SNR improved. Respiratory artifacts due to reduced liver signal intensity degraded navigator-gated image quality.

Conclusion: NC100150-Injection improves breath-hold coronary artery imaging. Navigator-gated acquisitions should use techniques that are insensitive to T2* effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Contrast Media
  • Coronary Vessels / pathology*
  • Dextrans
  • Ferrosoferric Oxide
  • Humans
  • Image Processing, Computer-Assisted
  • Iron*
  • Magnetic Resonance Angiography / methods*
  • Magnetite Nanoparticles
  • Middle Aged
  • Oxides*
  • Statistics, Nonparametric

Substances

  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • Oxides
  • ferumoxtran-10
  • Iron
  • Ferrosoferric Oxide